IGF-I and GH: Potential use in gene doping

Growth Hormone and IGF Research

Volumn 19, Issue 4, 2009, Pages 378-382

  Harridge, Stephen D R ^a   Velloso, Cristiana P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; HUMAN GROWTH HORMONE; MYOSIN LIGHT CHAIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; VIRUS VECTOR;

ARTICLE; ATHLETIC PERFORMANCE; DOPING; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; HUMAN; MOTOR PERFORMANCE; MUSCLE FORCE; MUSCLE GROWTH; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; SOMATIC GENE THERAPY; TRANSGENICS; UPREGULATION;

ANIMALS; ATHLETES; DEPENDOVIRUS; DOPING IN SPORTS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MUSCLES; RATS;

EID: 67749120200     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.04.016     Document Type: Article

References (37)

1. Sweeney H.L. Gene doping. Sci. Am. 291 (2004) 62-69
2. Haisma H.J., and de Hon O. Gene doping. Int. J. Sports Med. 27 (2006) 257-266
3. Harridge S.D.R., and Velloso C.P. Gene doping. Essays Biochem. 44 (2008) 125-138
4. Wells D.J. Gene doping the hype and the reality. Br. J. Pharmacol. 154 (2008) 623-631
5. Rivera V.M., P Gao G., Grant R.L., Schnell M.A., Zoltick P.W., Rozamus L.W., Clackson T., and Wilson J.M. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 105 (2005) 1424-1430
6. McPherron A.C., Lawler A.M., and Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387 (1997) 83-90
7. Cavazzana-Calvo M., Lagresle C., Hacein-Bey-Abina S., and Fischer A. Gene therapy for severe combined Immunodeficiency. Ann. Rev. Med. 56 (2005) 585-602
8. Shavlakadze T., Winn N., Rosenthal N., and Grounds M.D. Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm. IGF Res. 15 (2005) 4-18
9. Barton E.R. The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair. Appl. Physiol. Nutr. Metab. 31 (2006) 791-797
10. Owino V., Yang S.Y., and Goldspink G. Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett. 505 (2001) 259-263
11. Hameed M., Lange K.H., Andersen J.L., Schjerling P., and Kjaer M. S.D. Harridge et al., The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J. Physiol. 555 (2004) 231-240
12. Conover C.A., Baker B.K., Bale L.K., Clarkson J.T., Liu F., and Hintz R.L. Human hepatoma cells synthesize and secrete insulin-like growth factor Ia prohormone under growth hormone control. Regul. Pept. 48 (1993) 1-8
13. Sjögren K., Liu J.L., Blad K., Skrtic S., Vidal O., Wallenius V., LeRoith D., Törnell J., Isaksson O.G., Jansson J.O., and Ohlsson C. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl. Acad. Sci. USA 96 (1999) 7088-7092
14. Adams G.R., and Haddad F. The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J. Appl. Physiol. 81 (1996) 2509-2516
15. Czerwinski S.M., Martin J.M., and Bechtel P.J. Modulation of IGF mRNA abundance during stretch-induced skeletal muscle hypertrophy and regression. J. Appl. Physiol. 76 (1994) 2026-2030
16. Levinovitz A., Jennische E., Oldfors A., Edwall D., and Norstedt G. Activation of insulin-like growth factor II expression during skeletal muscle regeneration in the rat: correlation with myotubes formation. Mol. Endocrinol. 6 (1992) 1227-1234
17. Adams G.R., and McCue S.A. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J. Appl. Physiol. 84 (1998) 1716-1722
18. Rommel C., Bodine S.C., Clarke B.A., Rossman R., and Nunez L. T.N. Stitt et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell. Biol. 3 (2001) 1009-1013
19. Glass D.J. Skeletal muscle hypertrophy and atrophy signalling. Pathways. Int. J. Biochem. Cell. Biol. 37 (2005) 1974-1984
20. Jacquemin V., Butler-Browne G.S., Furling D., and Mouly V. V. IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes. J. Cell Sci. 120 (2007) 670-681
21. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., and Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412
22. Florini J.R., Ewton D.Z., and Coolican S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocrine Rev. 17 (1996) 481-517
23. Jacquemin V., Furling D., Bigot A., Butler-Browne G.S., and Mouly V. IGF-1 induces human myotube hypertrophy by increasing cell recruitment. Exp. Cell Res. 299 (2004) 148-158
24. Coleman M.E., DeMayo F., Yin K.C., Lee H.M., Geske R., Montgomery C., and Schwartz R.J. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270 (1995) 12109-12116
25. Musarò A., McCullagh K., Paul A., Houghton L., Dobrowolny G., Molinaro M., Barton E.R., Sweeney H.L., and Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet. 27 (2001) 195-200
26. Shavlakadze T., Boswell J.M., Burt D.W., Asante E.A., Tomas F.M., Davies M.J., White J.D., and Grounds M.D. C.Goddard, Rskalpha-actin/hIGF-1 transgenic mice with increased IGF-I in skeletal muscle and blood: impact on regeneration. Denervation and muscular dystrophy, Growth Horm. IGF Res. 16 (2006) 157-173
27. Hikida R.S., Knapp J.R., Chen W.Y., Gozdanovic J.A., and Kopchick J.J. Effects of bovine growth hormone analogs on mouse skeletal muscle structure. Growth Dev. Aging 59 (1995) 121-128
28. Kim H., Barton E., Muja N., Yakar S., and Pennisi P. D. Le Roith, Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo. Endocrinology 146 (2005) 1772-1779
29. Barton-Davis E.R., Shoturma D.I., Musaro A., Rosenthal N., and Sweeney H.L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. USA 95 (1998) 15603-15607
30. Lee S., Barton E.R., Sweeney H.L., and Farrar R.P. Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J. Appl. Physiol. 96 (2004) 1097-1104
31. Barton E.R. Viral expression of insulin-like growth factor-I isoforms promotes different responses in skeletal muscle. J. Appl. Physiol. 100 (2006) 1778-1784
32. Spangenburg E.E. D. Le Roith, C.W. Ward, S.C. Bodine, A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J. Physiol. 586 (2008) 283-291
33. Fiatarone-Singh M.A., Ding W., Manfredi T.J., Solares G.S., O'Neill E.F., Clements K.M., Ryan N.D., Kehayias J.J., Fielding R.A., and Evans W.J. Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am. J. Physiol. Endocrinol. Metab. (1999) E135-E143
34. Hameed M., Orrell R.W., Cobbold M., Goldspink G., and Harridge S.D. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J. Physiol. 547 (2003) 247-254
35. Kim J.S., Kosek D.J., Petrella J.K., Cross J.M., and Bamman M.M. Resting and load-induced levels of myogenic gene transcripts differ between older adults with demonstrable sarcopenia and young men and women. J. Appl. Physiol. 9 (2005) 2149-2158
36. Draghia-Akli R., and L Fiorotto M. A new plasmid-mediated approach to supplement somatotropin production in pigs. J. Anim. Sci. 82 (2004) E264-E269
37. Boateng J.S., Lancashire L., Ahmad M., Davy R., Ball B., Yang S.Y., Roberts J., Teale P., Velloso C., Rees R., Ball G., Goldspink G., and Creaser C. The use of proteomic and bioinformatic techniques for detecting serum protein biomarkers following growth hormone administration. The Inter. J. Genom. Proteom. 2 (2007)